Ignite Creation Date:
2025-12-24 @ 2:42 PM
Ignite Modification Date:
2025-12-30 @ 3:43 AM
Study NCT ID:
NCT05567159
Status:
COMPLETED
Last Update Posted:
2024-10-04
First Post:
2022-10-03
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
A Study of Donanemab (LY3002813) in Healthy Participants
Sponsor:
Eli Lilly and Company
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2022-10-04
Start Date Type:
ACTUAL
Primary Completion Date:
2023-07-14
Primary Completion Date Type:
ACTUAL
Completion Date:
2023-07-14
Completion Date Type:
ACTUAL
First Submit Date:
2022-10-03
First Submit QC Date:
None
Study First Post Date:
2022-10-05
Study First Post Date Type:
ACTUAL
Results First Submit Date:
2024-07-08
Results First Submit QC Date:
None
Results First Post Date:
2024-10-04
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2024-07-08
Last Update Post Date:
2024-10-04
Last Update Post Date Type:
ACTUAL